Today: 22 May 2026
Browse Category

Earnings 8 January 2026 - 14 January 2026

Infosys Q3 results: Profit hit by labour codes, but FY26 guidance gets a lift

Infosys Q3 results: Profit hit by labour codes, but FY26 guidance gets a lift

Infosys raised its FY26 revenue growth forecast to 3%-3.5% after Q3 revenue rose 8.9% to 454.79 billion rupees, but profit fell 2.2% due to a one-time 12.89 billion rupee charge from India’s new labour codes. Operating margin was 18.4%, adjusted to 21.2% excluding the provision. The company reported $4.8 billion in large-deal wins. Infosys shares closed up 0.6% ahead of earnings, but remain down 17% over the past year.
14 January 2026
···
Moderna stock jumps 12% after $1.9 billion 2025 sales view — what investors watch next

Moderna stock jumps 12% after $1.9 billion 2025 sales view — what investors watch next

Moderna shares jumped 11.7% to $37.81 after the company raised its 2025 sales outlook to about $1.9 billion and cut its operating expense forecast by $200 million. The company reiterated its 2026 growth target and said it does not expect flu or COVID-flu shots to be approved for the 2026 season. Investors await Feb. 13 results and early-2026 cancer vaccine data with Merck.
13 January 2026
··
ServiceNow stock rises after Goldman initiates coverage as CPI, earnings near

ServiceNow stock rises after Goldman initiates coverage as CPI, earnings near

ServiceNow shares rose 0.6% to $142.64 after Goldman Sachs initiated coverage with a Buy rating and a $205 price target. Traders now see a 95% chance the Fed will hold rates steady in January, as banks push expected U.S. rate cuts to late 2026. U.S. stocks hit record highs ahead of Tuesday’s inflation data and earnings season kickoff. ServiceNow will report Q4 and full-year 2025 results on Jan. 28.
13 January 2026
·
Moderna (MRNA) stock slips after $1.9B 2025 revenue view and cost cuts — what to watch next

Moderna (MRNA) stock slips after $1.9B 2025 revenue view and cost cuts — what to watch next

Moderna shares fell about 2% to $33.60 early Monday after the company forecast $1.9 billion in 2025 revenue and cut its GAAP operating-expense outlook. CFO James Mock said U.S. retail vaccination rates dropped 26% year-on-year, helping sales hit the low end of forecasts. Moderna expects to end 2025 with about $8.1 billion in cash, including a planned $600 million loan draw. CEO Stéphane Bancel announced a $2 billion annual expense cut for 2025.
12 January 2026
·
HCLTech Q3 results are out: Revenue beats estimates, profit drops and FY26 guidance narrows

HCLTech Q3 results are out: Revenue beats estimates, profit drops and FY26 guidance narrows

HCLTech posted a 13.3% rise in Q3 revenue to 338.72 billion rupees but saw profit fall 11.2% to 40.76 billion rupees after a 9.56 billion-rupee charge tied to new labour laws. The company cut its FY26 revenue growth forecast to 4%-4.5%. AI revenue jumped to $146 million, and new deal bookings reached $3 billion. Shares rose 0.34% ahead of results but are down over 16% in the past year.
12 January 2026
···
Goldman Sachs stock: IPO mandate, CPI and earnings set up a busy week for GS

Goldman Sachs stock: IPO mandate, CPI and earnings set up a busy week for GS

Goldman Sachs shares rose 0.4% to $938.98 Friday after being named an adviser on A.S. Watson’s planned dual IPO in Hong Kong and London, which could raise over $2 billion. Goldman will report quarterly results Thursday, following JPMorgan’s release Tuesday and the December CPI report. The bank also declared dividends on several preferred stock series, payable Feb. 10 to holders of record Jan. 26.
11 January 2026
·
P&G stock: 3 things to watch before Monday’s open

P&G stock: 3 things to watch before Monday’s open

Procter & Gamble shares closed up 0.2% at $141.87 Friday, lagging the S&P 500’s 0.65% rise. Shailesh Jejurikar took over as CEO Jan. 1, with Jon Moeller now executive chairman. The company will report fiscal Q2 results Jan. 22. U.S. December CPI data is due Jan. 13, with November retail sales set for Jan. 14.
11 January 2026
··
Microsoft stock holds near $480 as Copilot Checkout rollout sets up a Jan. 28 earnings test

Microsoft stock holds near $480 as Copilot Checkout rollout sets up a Jan. 28 earnings test

Microsoft shares rose 0.2% to $479.07 Friday after launching a Copilot checkout tool and new “agentic AI” features for retailers. The company, now valued at $3.85 trillion, will report fiscal Q2 results after markets close Jan. 28. Wells Fargo cut its price target to $665 but kept an Overweight rating. Some new retail AI features remain in preview, with adoption by merchants still uncertain.
9 January 2026
···
Applied Materials stock jumps toward $300 as TSMC sales beat and analysts lift AMAT targets

Applied Materials stock jumps toward $300 as TSMC sales beat and analysts lift AMAT targets

Applied Materials shares jumped about 6% Friday, briefly topping $300, after TSMC reported fourth-quarter revenue above forecasts. Other chip-equipment stocks also rose, with Lam Research up 8% and KLA up 5%. Investors are watching TSMC’s Jan. 15 outlook and Applied’s next earnings report for signs on 2026 spending.
9 January 2026
·····
JPMorgan stock climbs on Apple Card takeover as earnings near

JPMorgan stock climbs on Apple Card takeover as earnings near

JPMorgan shares rose 1.1% after announcing it will take over Apple Card from Goldman Sachs, a deal expected to bring over $20 billion in balances but close in about two years. The bank will record a $2.2 billion provision for credit losses tied to the agreement. Investors are watching for JPMorgan’s Jan. 13 earnings for signs of credit-card delinquencies and consumer spending shifts.
8 January 2026
···
Apple stock slips today as Apple Card shifts to JPMorgan, payrolls and earnings loom

Apple stock slips today as Apple Card shifts to JPMorgan, payrolls and earnings loom

Apple shares fell 0.8% to $260.33 in early Thursday trading after Alphabet surpassed its market value for the first time since 2019. Apple and JPMorgan said Chase will take over as Apple Card issuer in about 24 months, pending regulatory approval. Goldman expects the deal to add 46 cents per share to its Q4 2025 earnings. Investors await Friday’s U.S. jobs report and Apple’s Jan. 29 earnings call.
8 January 2026
····
Nokia Oyj stock slides in Helsinki as Kepler upgrade bounce fades ahead of Jan. 29 results

Nokia Oyj stock slides in Helsinki as Kepler upgrade bounce fades ahead of Jan. 29 results

Nokia shares fell about 4% to 5.534 euros in Helsinki on Thursday, reversing part of Wednesday’s gain after Kepler Cheuvreux upgraded the stock to “buy” and raised its target price to 6.60 euros. Another broker maintained a bearish stance. Investors await Nokia’s Jan. 29 earnings for updates on margins and cash flow. In U.S. trading, Nokia’s ADRs dropped 3.3% to $6.57.
8 January 2026
··
1 … 6 7 8 9 10 … 14

Stock Market Today

  • Q1 Earnings Review: Azenta Falls; West Pharmaceutical Leads Drug Development Services Stocks
    May 21, 2026, 9:31 PM EDT. Drug development inputs and services stocks, essential for pharmaceutical research and manufacturing, reported mixed Q1 results. Azenta (NASDAQ:AZTA), specializing in biological sample management, posted disappointing results with $144.8 million revenue, missing estimates and the weakest among peers, causing its share price to drop 23.4% to $17.65. Conversely, West Pharmaceutical Services (NYSE:WST), maker of specialized packaging and delivery devices, delivered a strong quarter with $844.9 million revenue, beating estimates by 8.4%. Overall, the sector's revenues beat consensus by 1.6%, despite an average 2.5% share price decline post-earnings. Tailwinds include growth in biologics and gene therapies, while headwinds feature pricing pressure and regulatory risks.

Latest articles

OpenAI Shares Hype Returns, Still No Ticker in Sight

OpenAI Shares Hype Returns, Still No Ticker in Sight

22 May 2026
OpenAI is preparing to confidentially file for a U.S. IPO, aiming to go public as early as September, sources told Reuters. The move follows a court win against Elon Musk, removing a key legal obstacle. Private-market share prices for OpenAI ranged from $658.94 to $732.38 this month, but no official public price exists. Ordinary investors still cannot buy OpenAI stock on public exchanges.
Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

22 May 2026
Estée Lauder and Spain’s Puig ended merger talks that would have created a $40 billion beauty group. Estée Lauder shares rose about 10% in after-hours trading, closing the regular session at $78.91. The company said it will focus on its turnaround plan and continue reviewing possible acquisitions or divestitures.
WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

22 May 2026
WhiteFiber shares jumped 22.2% to $29.55 after announcing a five-year AI compute contract worth over $160 million for a Paris-region deployment using NVIDIA GPU systems. Google Finance showed the stock rising further after hours. The project is backed by planned financing and 12 months of customer prepayments, but funding and execution remain pending. Service is expected to start in July, subject to equipment delivery and acceptance.
Go toTop